Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

Name: Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension
License: Public Domain

Novartis Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

essential hypertension

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 332836
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.